Reply To: Modulation of Toll-Like Receptor 9 Expression on Monocytes of Viral Hepatitis Patients

Hou J. , Boonstra A. Modulation of Toll-like receptor 9 expression on monocytes of viral hepatitis patients. Antivir Ther 2014; doi: 10.3851/IMP2828.

Huang Y.W. , Hsu C.K. , Lin S.C. Reduced Toll-like receptor-9 expression on peripheral CD14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy. Antivir Ther 2014; 19: 637–643.

Huang Y.W. , Lin S.C. , Wei S.C. Reduced Toll-like receptor-3 expression in chronic hepatitis B patients and its restoration by interferon therapy. Antivir Ther 2013; 18: 877–884.

Wieland S.F. , Chisari F.V. Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol 2005; 79: 9369–9380.

Bertoletti A. , Ferrari C. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Gut 2012; 61: 1754–1764.

Yu S. , Chen J. , Wu M. Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/ IKKepsilon and DDX3. J Gen Virol 2010; 91: 2080–2090.